A Study of Injection HB002.1T in Subjects With Solid Tumor

NCT03636750 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor

Interventions

DRUG: HB002.1T

Sponsor

Huabo Biopharm Co., Ltd.